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Straightforward access to biocompatible
poly(2-oxazoline)-coated nanomaterials by
polymerization-induced self-assembly†
Dao Le, ‡ab Friederike Wagner,‡ab Masanari Takamiya,a I-Lun Hsiao,ac
Gabriela Gil Alvaradejo,ab Uwe Strähle,a Carsten Weissa and
Guillaume Delaittre *ab
We report the synthesis of poly(2-ethyl-2-oxazoline)-based (PEtOx)
nanoobjects by polymerization-induced self-assembly (PISA). First, well-
defined PEtOx macromolecular chain transfer agents were synthesized by
cationic ring-opening polymerization and click chemistry. The photoini-
tiated PISA of 2-hydroxypropyl methacrylate mediated by these PEtOx
produced nanoobjects spanning the full range of core–shell morpholo-
gies. The nanoparticles exhibited high biocompatibility and stealth proper-
ties in vitro or in vivo, as well as thermoresponsive behavior.
Poly(2-alkyl/aryl-2-oxazoline)s (PAOx), synthesized by cationic ring-
opening polymerization (CROP), are valuable polymers in the biome-
dical field, thanks to their biocompatibility, stealth behavior, and
chemical and physical versatility.1–4 Coinciding with the recently
renewed interest in PAOx, the first poly(2-ethyl-2-oxazoline) (PEtOx)
conjugate has already entered phase II clinical trials for the treatment
of Parkinson’s disease.5 Several studies have focused on the synthesis
of functional PAOx to achieve functional hydrogels,6–8 surface
coatings,9 andpolymer–peptide/protein/drug conjugates.10,11 Besides,
the interest in PAOx-based complex structures is also increasing.12
PEtOx brush-arm star and comb-shaped polymers incorporating
nitroxide radicals and perfluorinated segments, respectively, have
been reported for magnetic resonance imaging.13,14 Patterned PEtOx
bottlebrush copolymer brushes on diamond were reported for bio-
sensor design.15 Notably, PAOx-based core–shell nanoparticles (NPs)
are promising nanocarriers for biomedicine.16 Until now, these have
been exclusively prepared by classic self-assembly of pre-synthesized
amphiphilic block copolymer (ABCP).
Polymerization-induced self-assembly (PISA), developed in the
last decade, has become an important approach for the fabrication
of ABCP NPs with elaborate and precise macromolecular architec-
ture, colloidal morphology, and functionality.17–23 In a nutshell, PISA
rests upon two events: (i) chain extension of a solvophilic macro-
molecular precursor with a monomer forming a solvophobic block
and (ii) synchronous self-assembly of the so-formed amphiphilic
block copolymer leading to core–shell NPs. As opposed to the classic
nanoprecipitation–solvent exchange/evaporation method, PISA can
be performed at a high polymer concentration (up to 50 vs. 1–2 wt%)
and gives in situ access to morphologies as diverse as plain spheres,
rods/fibers, and hollow vesicles. Reversible-deactivation radical poly-
merization, mostly reversible addition–fragmentation transfer
(RAFT) polymerization, is the major underlying polymerization
mechanism for PISA, occurring under either dispersion or emulsion
polymerization conditions with styrene, (meth)acrylate, or (meth)-
acrylamide monomers. Other polymerization mechanisms are slowly
making an appearance in the PISA realm, such as ring-opening
metathesis polymerization,24–27 in order to expand the chemistry and
functionality of NPs.28 However, because of the interest in greener
solvents and the general requirement for polar solvents to produce
biocompatible nanoparticles (i.e., alcohols and water), employment
of ionic polymerization is still limited.29 Therefore, many interesting
biocompatible polymers such as PAOx have not yet been included in
PISA nanoobjects.
In this study, we describe the first combination of CROP and
RAFTPISA to obtain PAOx-based nanoobjects spanning a wide range
of morphologies. First, dithiobenzoate-functionalized PAOx were
prepared by CROP of a 2-oxazoline monomer in an aprotic solvent,
followed by capping to introduce the chain transfer agent (CTA)
moiety necessary for the RAFT polymerization. The functional PAOx
were then used as a macromolecular CTA (macroCTA) in photo-
initiated aqueous RAFTPISA (photoRAFTPISA). The influence of
several parameters on the morphology was investigated, i.e., mode
of synthesis of the macroCTAs, chain length ratio between the
solvophilic and solvophobic blocks, and concentration. Besides, we
demonstrate that the obtained NPs are biocompatible in vitro and
in vivo, and hence are suitable for potential bioapplications.
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In particular, PEtOx was used in this study for its great hydro-
philicity and its potential as an alternative to the established
polyethylene glycol (PEG).30 PEtOx was synthesized by CROP using
methyl tosylate as an initiator. As shown in Scheme 1, the CTA
end group could be incorporated either by direct capping with a
deprotonated carboxylic acid-functionalized CTA (Route A)31,32 or by
a two-step sequence consisting of a nucleophilic substitution with
sodium azide and a subsequent copper-catalyzed azide–alkyne
cycloaddition (CuAAC) (Route B). Both routes showed similar kinetic
features and fulfilled elementary criteria for a controlled/living
polymerization, i.e., linear increase of pseudo-first order plot, linear
increase of number-average molar mass with conversion, and a clear
shift of size-exclusion chromatography (SEC) traces (Fig. S2, ESI†).
However, the nature of the capping reaction impacted the dispersity
of the PEtOx (Ð); the Ð values were systematically slightly higher
when capping with the carboxyl CTA, as compared with NaN3,
concomitant with the presence of a significant shoulder at higher
molar masses on the SEC traces (Fig. S2C, ESI†). In Route B, reaction
conditions to introduce the CTA moiety by CuAAC (time, solvent)
also influenced the shape of the molar mass distribution (MMD) and
Ð (Fig. S7, ESI†). Performing CuAAC for 4 hours in dichloromethane
(DCM) led to the smallest broadening of the MMD. This shouldering
phenomenon may be – at least to some extent – due to partial
decomposition of the CTA moiety to a thiol, which can be readily
oxidized to disulfide and produce high molar mass coupled species
(Fig. S5B and C, ESI†).33 Indeed, CuAAC of PEtOx-N3 with propargyl
alcohol in similar conditions led to a significant reduction of MMD
broadening (Fig. S8, ESI†). Overall, Route B required one more step
but provided well-defined polymers with Ð r 1.2 (Fig. S9, ESI†). For
each route, two batches of PEtOx-CTAs were synthesized for the PISA
experiments, with Mn of approx. 5500 and 9500 g mol
1. The
characteristics of these polymers are listed in Table S1 (ESI†).
1H NMR and SEC coupled to electrospray ionization mass spectro-
metry (SEC-ESI-MS) data ascertained high RAFT functionality in all
polymers (Fig. S3, S4, S10–S12, ESI†). The chain extension experi-
ments with benzyl methacrylate in solution confirmed the previous
trends: while macroCTAs from Route A underwent only partial chain
extension (Fig. S13, ESI†), Route B led to clean block copolymers
(Fig. S14 and S15, ESI†). Nevertheless, as a living character is not
mandatory to obtain nanoparticles by PISA,34 we further employed
all four macroCTAs.
2-Hydroxypropyl methacrylate (HPMA) was used as a core-forming
monomer in water. Since PEtOx exhibits a lower critical solution
temperature in water at approx. 60 1C,35 photopolymerization at 25 1C
was applied to maintain good solubility and the ability for steric
stabilization. Firstly, PISA experiments with the short PEtOx-CTA M1
were performed with varying targeted degrees of polymerization of
HPMA (DPHPMA) and total solids content (Table S3, ESI†). All PISA
experiments were conducted for 3 h and led to complete conversion
of HPMA, as verified by 1H NMR spectroscopy (Fig. S16, ESI†). As
observed by TEM, only pure spherical NPs were obtained in the
DPHPMA = 30–100 range at 5 wt% solids (Fig. S18, left, ESI†). At
10 wt%, a mixture of spheres and nanofibers was obtained for
DPHPMA = 50 (Fig. S18, right, ESI†). Higher DPHPMA or solids
concentration led to precipitation. Similar results were achieved
for the CuAAC-based PEtOx-CTA M3 with mainly plain spherical
morphology but also large, possibly multicompartmented particles
(Table S5 and Fig. S22, ESI†). While both short PEtOx-CTAs seemed
to provide insufficient stabilization and led to aggregation at
high DPHPMA and high concentration, PISA with longer analogs
allowed the formation of nanoobjects spanning the full range of
morphologies. Pure spheres, worm-like nanofibers, vesicles as well as
morphology mixtures were obtained with M2 (Table S4 and Fig. S20,
ESI†). Higher-order morphologies evolved with increasing DPHPMA
and solid contents. However, a significant rise in dispersity was also
observed, which is most probably due to non-reinitiating PEtOx-CTA
rather than to a loss of control. Indeed, SEC traces of PISA samples
showed important amounts of low-molecular-mass species con-
sistent with non-functionalized PEtOx and unreacted POx-CTA
(Fig. S19, ESI†). By using the better-defined PEtOx-CTA M4,
strongly improved MMDs were obtained with a total consump-
tion of POx-CTA (Fig. S23, ESI†). Concomitantly, the PISA NPs
displayed well-defined morphologies, as well as further more
intricate shapes such as donut- and jellyfish-like (Fig. 1). At low
solids content (5 wt%) and with DPHPMA up to 200, only spheres
or donuts were observed, as for higher solids content with
DPHPMA r 100. However, a range of nanoobjects from spheres
to vesicles was achieved when targeting higher DPHPMA above
5 wt%. In particular, conditions for the preparation of pure phases
were established, even for jellyfish-like objects, an intermediate
stage of the nanofiber-to-vesicle morphological transformation.
PISA with higher-molar-mass PEtOx-CTAs, therefore, gave better
results in terms of colloidal stability and morphology control. There
is, however, no clear influence of the degree of livingness of the
macromolecular CTAs on the morphological control.
In analogy to systems reported by Armes and co-workers,36 phase
transition of the final dispersions could be triggered by changing
temperature. At high concentration, the vesicle-to-nanofiber-to-sphere
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transitions were reversible, irrespective of the initial state, e.g.,
nanofibers and vesicles for M4-b-PHPMA125 and M4-b-PHPMA175
at 25 1C, respectively (Fig. 2A). Such order–order transitions in
a narrow temperature range are due to not only the weakly
hydrophobic nature of the core-forming PHPMA block37 but also
the temperature-dependent solubility of PEtOx. However, at low
concentration, e.g., 0.1 wt%, the transitions became irreversible
(Fig. 2B) because the fusion of spheres or fibers is less likely under
these conditions. For instance, vesicles of M4-b-PHPMA125 obtained
by heating a concentrated solution at 40 1C and carefully diluted at
the same temperature irreversibly led to nanofibers, then spheres
by gradual cooling.
Since PEtOx is considered as an attractive alternative to PEG for
in vivo applications, we sought to preliminarily assess the biocom-
patibility and blood circulation behavior of the present PEtOx-coated
NPs. For imaging purposes, fluorescent NPs were thus produced by
simply adding a small amount of fluorescein methacrylate (FMA) or
rhodamine 4-vinylbenzyl ester (RVB) comonomer to a PISA recipe
(Scheme S2, ESI†). Spherical NPs with intensity-average hydro-
dynamic diameters of 40 and 60 nm were obtained (Table S7 and
Fig. S27, ESI†) and expected maxima absorption and emission
for fluorescein and rhodamine B (Fig. S28, ESI†).
To assess the biocompatibility and ability of the FMA-labeled
PEtOx NPs to evade clearance by the reticuloendothelial system
(RES), murine macrophages (RAW 264.7), human umbilical vein
endothelial cells (HUVEC), and human epithelial lung cancer
cells (A549) were incubated for 24 h, using fluorescein-labeled
carboxylated polystyrene (PS-COOH) NPs as a reference material.38
The RVB-labeled NPs were administered to zebrafish embryos and
their biocompatibility, biodistribution, and clearance were examined
for 24 h post-injection (hpi). As controls, PS-COOH NPs as well as
rhodamine-labeled dextran were used in parallel. Both in vitro and
in vivo studies are reported in more detail in the ESI.†
Briefly, as expected for the NPs covered with stealth polymers, the
PEtOx NPs show none-to-very low uptake in all cell types and did
not reduce cell viability up to 100 mg mL1 (Fig. S31–S33, ESI†). In
the zebrafish embryos, no noticeable morphological or behavioral
changes were detected after intravenous injection of a 1 mg mL1
dispersion of the RVB-labeled NPs (Fig. 3). In contrast to dextran,
which was rapidly cleared and only slightly accumulated in the
endothelial cells in the caudal vein (CV) after 24 h (C, F, C0, and F0),
the RVB-PEtOx NPs mainly circulated in the bloodstream (B, E and
B0, E0). For comparison, the PS-COOH NPs were not detected in the
circulation but were, as expected, entrapped in the RES (macro-
phages and endothelial cells) in the CV (D, and D0). However,
contrary to the more simplistic in vitro experiments employing
murine macrophages, a small fraction of RVB-PEtOx NPs could be
detected in macrophages in vivo (E, and E0). In summary, our PEtOx
NPs are biocompatible and display enhanced retention in the blood
circulation. Furthermore, to accurately monitor clearance by the RES,
the zebrafish model seems to be better suited than the conventional
cell culture studies.
In the present communication, we described for the first
time the synthesis of biocompatible PAOx-based diblock copolymer
NPs by PISA. Control of morphology was achieved by varying the
lengths of each block as well as the reaction mixture concentration.
Dispersions based on pure phases of spheres, fibers, or vesicles were
obtained. The nanoobjects display a thermosensitive behavior,
enabling morphological transformation, which could be an asset
Fig. 1 (top) Phase diagram for RAFTPISA of HPMA using PEtOx-CTA M4 as
macroRAFT agent and (bottom) TEM images of representative samples (empty
symbols from above). Larger TEM images are provided as Fig. S25 (ESI†).
Fig. 2 Temperature-induced morphological transformation of (A) original
nanofibers (M4-b-PHPMA125, 20 wt% at 25 1C) and vesicles (M4-b-
PHPMA175, 15 wt% at 25 1C) in as-synthesized dispersions, and (B) vesicles
(M4-b-PHPMA125, 0.1 wt% at 40 1C) at low concentration. Representative
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for the preparation of bioactive materials. Importantly, the present
PEtOx-based nanoparticles are non-toxic and exhibit prolonged
circulation in the bloodstream. The versatility of PISA combined
with the high potential of polyoxazolines in drug delivery and
bioscaffolding promises rapid access to corresponding functional
(nano)materials.
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Fig. 3 (A) Schematic of a 3 day-post-fertilization zebrafish embryo high-
lighting the artery (red), vein (blue), and site of NP injection, as well as the
imaged region (rectangular region) shown in panels (B–F). The orientation
of the embryos is dorsal up, anterior left. (B–D) Caudal region of zebrafish
embryos at 24 hpi injected with either PEtOx NPs (magenta, B),
rhodamine-conjugated 3 kDa dextran (magenta, C) or PS-COOH NPs
(magenta, D). Blood vessels are demarcated with transgenic fluorescence
(green). (E and F) The same region of the embryos highlighting the location
of macrophages (green, arrows) injected either with PEtOx NPs (E) or
dextran (F). ca: caudal artery; cv: caudal vein; m: macrophage; n: noto-
chord. Scale bar: 100 mm (B–F) and 20 mm (B 0–F0).
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